Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer

Chi-Hwan CHOI; Won-Dong KIM; Sang-Jeon LEE; Woo-Yoon PARK.
Radiation Oncology Journal ; : 99-107, 2012.
Artículo en Inglés | WPRIM | ID: wpr-97539

Documentos relacionados

  1. Towards voltammetric point of care detection of leucovorin.
  2. Folinic acid over rescue of high dose methotrexate: How problematic citations conserve discredited concepts.
  3. Adequate SIRT activity dose is as important as adequate chemotherapy dose.
  4. [Primary appendiceal signet ring cell carcinoma:a case report].
  5. 5-Fluorouracil Induced Hypertriglyceridemia During the Colorectal Cancer Treatment in a Patient With Multifactorial Chylomicronemia Syndrome: A Case Report.
  6. The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study.
  7. Poisoning related to therapeutic error in prolonged low-dose methotrexate treatment.
  8. Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer.
  9. Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT Trial.
  10. Perioperative chemotherapy for gastric cancer in FLOT4.